| Financial Year |
March 31 2023 |
| Monetary Funds |
3,433,012,197.33 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
9,589,569.25 |
| Advances to Suppliers |
213,813,659.00 |
| Other Receivables |
1,220,572,308.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,566,250.10 |
| Inventories |
9,360,430,736.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
35,147,295.52 |
| Total Current Assets |
14,489,824,366.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,600,000.00 |
| Long-term Equity Investment |
331,392,330.12 |
| Investment Properties |
557,095.45 |
| Fixed Assetes |
3,771,225,126.27 |
| Under-construction Projects |
236,608,904.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
2,368,149.90 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
652,383,338.04 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,036,283.77 |
| Deferred Income Tax Assets |
55,602,311.79 |
| Other Non-Current Assets |
137,663,637.39 |
| Sub-Total of Non-Current Assets |
5,322,796,873.67 |
| Total Assets |
19,812,621,240.45 |
| Short-Term Loans |
5,374,799,544.71 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,503,744.00 |
| Accounts Payable |
1,294,206,411.25 |
| Accounts Received In Advance |
2,157,770.63 |
| Employee Compensation Payable |
87,082,895.51 |
| Taxes Payable |
55,843,150.45 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
128,194,215.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,086,888,252.55 |
| Other Current Liabilities |
11,217,975.11 |
| Sub-Total of Current Liabilities |
8,383,385,098.54 |
| Long-term Loans |
1,001,310,891.92 |
| Bonds Payable |
1,500,000,000.00 |
| Long-Term Accounts Payable |
446,579,812.50 |
| Special Payable |
-- |
| Estimatied Liabilities |
52,273,509.91 |
| Deferred Income Tax Liabilities |
17,675,832.52 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,094,328,840.10 |
| Total Liabilities |
11,477,713,938.64 |
| Paid-In Capital(Or Share Stock) |
1,148,014,400.00 |
| Capital Surplus |
3,019,148,161.20 |
| Surplus Reserve |
459,644,750.30 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,735,098,203.78 |
| Minority Stockholder's Interest |
-77,763,398.13 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,412,670,699.94 |
| Owner's Equity（Stockholder's Equity） |
8,334,907,301.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
19,812,621,240.45 |
